Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialisation of innovative medicines for rare neuromuscular neuromuscular and pulmonary diseases with high unmet medical need, has announced an equity financing of CHF 20
Tags :Eduard de Zordi
Adecco Group has successfully priced its EUR 500 million Subordinated Fixed-to-Reset Rate Securities due 2082. Settlement will take place on September 21, 2021. The hybrid bonds were issued by Adecco International Financial Services B.V. and guaranteed, on a
On September 7, 2021, Adecco Group successfully raised approximately EUR 232.29 m (CHF 252.96 m) through the placement of 5.1 m new shares by way of an accelerated bookbuild offering. The offering was done by way of a private
Allgemeine Baugenossenschaft Zürich (ABZ), a non-profit housing cooperative, launched and priced its issuance of CHF 120 million total nominal amount of 0.25% Sustainability Bonds 2021-2031. The bonds have been offered in full compliance with the Financial
Raiffeisen Schweiz Genossenschaft, a Swiss systemically relevant bank, issued AT1 Bonds in the total amount of CHF 300 million. With a base tranche of CHF 200 million on 31 March 2021 and a first reopening of CHF 100 million on 1
Québec issued CHF 250 million Bonds. Deutsche Bank London Branch, acting through Deutsche Bank Zurich Branch acted as Lead Manager. The Bonds will be listed on the SIX Swiss Exchange. Homburger advised Deutsche Bank Zurich
Homburger is acting as legal advisor for Siegfried Holding in the placement of a CHF 200 million 0.20% Senior Bond due 2026. The bonds will be admitted for trading and listing on the SIX Swiss Exchange. The closing
The Goldman Sachs Group issued CHF 450 m Bonds on May 11, 2021. Credit Suisse – advised by Homburger – acted as lead manager, together with Commerzbank Aktiengesellschaft and Goldman Sachs International. The bonds will be listed on the Six
Homburger acted as legal counsel for Zürcher Kantonalbank in the issuance of EUR 500 m 0.00 per cent senior bonds due May 15, 2026. Homburger team was led by partner Benjamin Leisinger (Capital Markets, pictured) and included counsel
Homburger advised Santhera Pharmaceuticals Holding on the settlement of its first exchange offer for a convertible bond in Switzerland. Holders of current Santhera CHF 60 Unsecured Convertible Bonds due in 2022 have received new CHF 30,270,375 Senior Unsecured
